Dr. RShatsky @dr-rshatsky.bsky.social · 09/04/2025#medSky #OncSKy Oncology/Medical community on here are any of you considering leaving the country given the political climate? I don’t want to raise my kids in a dictatorship and it’s getting more and more hopeless here. Would love to hear people’s thoughts😔 3101
Dr. RShatsky @dr-rshatsky.bsky.social · 08/04/2025www.nature.com/articles/s41...nature.comSynthetic GPCRs for programmable sensing and control of cell behaviour - NatureModular synthetic G-protein-coupled receptors with nanobody-based ligand-recognition domains can be designed and used to programme transgene expression, real-time fluorescence or endogenous G-protein ... 050
Reposted by Dr. RShatskySociety for Immunotherapy of Cancer @sitcancer.bsky.social · 18/03/2025New Journal for ImmunoTherapy of Cancer ( #JITC ) article: Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors bit.ly/41wAsiY #MedSky #OncSky #CanSky #cancer #research 072
Reposted by Dr. RShatskyDaniel Sunderland, DO @thebandageman.bsky.social · 18/03/2025#cancer #medsky #VaccinesSaveLives 093
Dr. RShatsky @dr-rshatsky.bsky.social · 08/03/2025I found the puppies at Miami Breast and they made me soooo happy #MBCC25 0240
Dr. RShatsky @dr-rshatsky.bsky.social · 02/03/2025OK who’s joining me at Miami breast this week? Not excited about spending money in a state like Florida, but am excited to speak about management of breast cancer during pregnancy and getting pregnant after breast cancer!! #OncSKY #MedSky#CanSKY 1303
Reposted by Dr. RShatskyMedCaseCME @medcasecme.bsky.social · 28/02/2025📢 all🩺#oncology #bcsm #MedSky #OncSky 🎯#TNBC patient case CME w/ @dr-rshatsky.bsky.social y.social & @ptarantinomd.bsky.social ✍️Supported by an edu grant from Gilead Sciences 🆓 #CME info 🔗 bit.ly/tnbc_casesim Provided by @bonumce.bsky.social 🖱️👇Scroll down to start 121
Dr. RShatsky @dr-rshatsky.bsky.social · 24/02/2025I spend my precious free time hiding from reality and enjoying every single moment I can with my family. Yesterday Er_OncDoc the kids a s I supported our beloved San Diego zoo! #MedSky 1200
Reposted by Dr. RShatskyAnne Fallon, MD @annefallon.bsky.social · 23/02/2025These weren’t lazy bureaucrats doing unimportant work. They were working hard, and often for less money than they could get in the private sector, on key life-saving public health programs. They were fired to give more money to billionaires. #DOGEkills #medsky www.propublica.org/article/trum...propublica.orgThey Worked to Prevent Death. The Trump Administration Fired Them.Public health teams are being gutted, imperiling efforts to safeguard organ donation and prevent maternal and infant death. Many workers expressed fear at what would happen to the work they left behin... 084
Reposted by Dr. RShatskyTimothy Caulfield @caulfieldtim.bsky.social · 05/02/2025Misinformation on social media is winning – scientists must adapt healthydebate.ca/2025/02/topi... via @healthydebate.bsky.social "It’s not just about vaccines or pandemics – misinformation about ADHD, cancer treatments, weight loss, fertility & chronic disease management thrives online."healthydebate.caMisinformation on social media is winning – scientists must adapt or lose the battle - Healthy DebateScientists and health professionals must rethink how we communicate or risk further marginalization in the public discourse. 410441
Reposted by Dr. RShatskyLouise in Ontario🇨🇦 @grammalou.bsky.social · 05/02/2025Healthcare workers are very welcome in Canada. #MedSky 1288
Reposted by Dr. RShatskyNEJM.org @nejm.org · 05/02/2025Internal Medicine rounds are never “aggressively boring” with Dr. G. Watch the latest video in which @glaucomflecken.bsky.social summarizes the PICNIC trial: www.tiktok.com/@nejm.org/vi... #MedSkytiktok.com“To spice things up, I thought we could end rounds with a game show quiz!” Our latest video in our partnership with @drglaucomflecken explains the results of the PICNIC trial, which investigated wheth...TikTok video by NEJM 0274
Reposted by Dr. RShatskyDirect Neurology @directneurology.bsky.social · 01/02/2025Archive your favorite links, #medsky. www.theatlantic.com/health/archi...theatlantic.comCDC Data Are DisappearingThe agency has already removed scientific data from public view. More could follow. 243
Dr. RShatsky @dr-rshatsky.bsky.social · 30/01/2025I am definitely burning the candle at both ends. Spoke at the USC breast symposium last weekend and speaking at the UCSD Binyatara conference this weekend. A friend did get a good pic or me wildly gesticulating last weekend though😆. This is my the SOC is not enough face!!! #CanSKy #MedSky 1170
Dr. RShatsky @dr-rshatsky.bsky.social · 28/01/2025Just when you thought your day (or month) couldn’t get any worse…. you pull a muscle in your neck…and well. It’s so much worse 😑. I’m not sure what this emoji I just found is supposed to be, but I think it’s what I need right now 💆🏼♀️media.tenor.coma cartoon of two cats laying next to each other with the words you giving me a neck and shoulder massageALT: a cartoon of two cats laying next to each other with the words you giving me a neck and shoulder massage 040
Dr. RShatsky @dr-rshatsky.bsky.social · 24/01/2025Most mom’s in their mid 40’s invest in cute jeans and yoga pants for themselves. But when you’re an oncology nerd on the academic conference speaking circuit. It’s badass suits that make all the difference and my houndstooth game is strong. #Medsky #AcademicMedicine #CanSky #OncSky 5511
Dr. RShatsky @dr-rshatsky.bsky.social · 23/01/2025After all the experience I’ve had with Dato D’xd I JUST found out they named it Datroway. Why was that so hush hush for so long?? #MedSky #CanSky #OncSKy www.clinicaloncology.com/Solid-Tumors...clinicaloncology.comFDA Approves Datroway for Unresectable or Metastatic, HR-positive, HER2-negative Breast CancerThe FDA has approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo), a Trop-2−directed antibody and topoisomerase inhibitor conjugate, for adult ... 182
Dr. RShatsky @dr-rshatsky.bsky.social · 23/01/2025Reading the news headlines is making me so ill I needed my bestie in bed tonight. Pray for your cancer researchers to keep their jobs amid the Trump administration freezing the NIH study section groups. #CanSky #OncSky #MedSky 2343
Dr. RShatsky @dr-rshatsky.bsky.social · 22/01/2025The new administration is here and I’m scared to look and find out what important life saving health measures are being cut each day. Yesterday was the plan to lower Medicare drug costs for seniors. What will tomorrow hold? #MedSky 130
Dr. RShatsky @dr-rshatsky.bsky.social · 16/01/2025Posting this as a PSA. There seems to have been some article in the media about City of Hope’s Ivermectin phase 1 in TNBC. It has been open since 2021. Not looking good. Stop messaging your poor oncologist about this. It is not some miracle cure. #MedSky #CanSky 1256
Dr. RShatsky @dr-rshatsky.bsky.social · 15/01/2025And after a long day of clinic and a inaugural BlueSky breast cancer chat I get home to this! I’m a lucky lady! ❤️ He looks better in it than I do for sure. #MedSky 1400
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202519/20 #TumorBoardTuesday @dr-rshatsky.bsky.social 👉For instance: Feb 2024, ARV-471, an investigational, oral PROTAC studied in the phase 3 VERITAC-2 trial, received FDA fast-track designation. www.pfizer.com/news/announc...pfizer.comArvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer | PfizerVepdegestrant is an investigational PROteolysis Targeting Chimera (PROTAC®) protein degrader designed to target and degrade the estrogen receptor (ER) protein 264
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202518/20 #TumorBoardTuesday @dr-rshatsky.bsky.social Beyond SERDs/SERMs…novel endocrine therapies targeting other mechanisms in pipeline: Proteolysis targeting chimeras (PROTACs), selective ER covalent antagonists, complete ER antagonists just to name a few!🤯 453
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202517/20 #TumorBoardTuesday @dr-rshatsky.bsky.social Beyond EMBER-3, novel combinations with SERDs and SERMs also being evaluated with CDK4/6i 154
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202517/20 #TumorBoardTuesday @dr-rshatsky.bsky.social ➡️Multiple novel SERDS studied in HR+/HER2- ABC 👍Elacestrant currently remains the only FDA approved option 🚧Novel SERDs w/ unique AEs from fulvestrant ⚡This is a rapidly changing landscape! 183
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202516/20 #TumorBoardTuesday @dr-rshatsky.bsky.social 🔙 to our case EMBER3 would be a great option, but based on availability, pt got elacestrant 🚫 abema+fulvestrant: -ESR1 Y537S 👉fulvestrant resistance. -POSTMONARCH👉modest PFS benof abema+fulv vs placebo+fulv AND 🚫benefit in subgroup w/ prior ribo 153
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202515/20 #TumorBoardTuesday @dr-rshatsky.bsky.social 👩⚕️Mini Tutorial 6👩⚕️ Imlunestrant: favorable safety profile vs SoC. Dc rate: 4% Imlun+abema: diarrhea=most common AE, all grade: 86%, grade≥3: 8%. Dc rate: 6% No 👁️or 💙AE signals like in other oral SERDS (i.e. photopsia, bradycardia in camizestrant) 353
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202514/20 #TumorBoardTuesday @dr-rshatsky.bsky.social 👩⚕️Mini Tutorial 5👩⚕️ 🔑Findings: PFS ESR1m: 5.5 (Imlun) vs 3.8 mon (SoC). HR= 0.62, p<0.001 PFS all: 9.4 (Imlun+abema) vs 5.5 mon (imlun). HR=0.57, p<0.001 Benefit of imlun+abema in key subgroups: ESR1m, PIK3CAm, visceral disease, prior CDK4/6i 164
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202513/20 #TumorBoardTuesday @dr-rshatsky.bsky.social 👩⚕️Mini Tutorial 4👩⚕️ Novel, oral SERDs in development w/ ⬆️efficacy ⬇️toxicities 👉💡imlunestrant, studied in the EMBER-3 trial presented at #SABCS24 🔑Pt features: ~37% with ESR1m, ~40% with PIK3CAm, >50% visceral disease 👉1/3 adj ET, 2/3 prior CDK4/6i 364
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202512/20 #TumorBoardTuesday @dr-rshatsky.bsky.social 2023, FDA approved elacestrant based on the EMERALD trial Pts: prior 1-2L ET, ≤1 chemo for ABC: R 1:1 ➡️elacestrant vs SoC ➡️ PFS all: HR = 0.70; p = .002 PFS ESR1m: HR = 0.55; p = .0005 Benefit in key subgroups: PIK3CA mut, ESR1 mut, and TP53 mut 153
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202511/20 #TumorBoardTuesday @dr-rshatsky.bsky.social 👩⚕️Mini Tutorial 2👩⚕️ ESR1 mutations are present in: ~4% of 1L setting ~30% in 2L+ setting 👉Not all ESR1 mutations are created the same! -ESR1 Y537S is associated with relative resistance to fulvestrant! pmc.ncbi.nlm.nih.gov/articles/PMC... 243
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202510/20 #TumorBoardTuesday 👩⚕️Mini Tutorial 1👩⚕️ Therapy options after progression on 1L ET+CDK4/6i are biomarker driven. @dr-rshatsky.bsky.social 253
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/202510/20 #TumorBoardTuesday What would you select as next line of therapy? 1. Abemaciclib+fulvestrant 2. Elacestrant 3. Evaluate for clinical trials involving novel SERDs @dr-rshatsky.bsky.social 153
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20259/20 #TumorBoardTuesday ⭐Case 2⭐ 50 y/o postmenopausal F with de novo metastatic invasive ductal carcinoma, ER >95%, PR >95%, HER2– (IHC2+) involving the 🦴 and liver (intact function), progressed on 1st line ribociclib+AI after 12 months, w/ ESR1 Y537S mutation on ctDNA🤔 @dr-rshatsky.bsky.social 253
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20258/20 #TumorBoardTuesday ⚖️ efficacy with safety… Inavo arm: ↑AEs vs control All-grade hyperglycemia: 58.6%; grade 3 or 4: 5.6% All-grade stomatitis: 51.2%; grade 3 or 4: 5.6% All-grade diarrhea: 48.1%; grade 3 or 4: 3.7% 1° ppx for above was not offered in the trial @dr-rshatsky.bsky.social 254
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20257/20 #TumorBoardTuesday Back to our case🔎 Pt started inavo, palbo, and fulv 2 weeks in, developed grade 2 stomatitis self-dced inavo and palbo Started dexamethasone+mucositis mouthwash, but sxs not resolved Currently undergoing evaluation for subsequent therapy @dr-rshatsky.bsky.socialmedia.tenor.coma small yellow duck is laying on a table next to a notebook and the word no .ALT: a small yellow duck is laying on a table next to a notebook and the word no . 453
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20256/20 #TumorBoardTuesday 👩⚕️Mini Tutorial 3👩⚕️ Pts R 1:1 to Inavo vs placebo +palbo+fulv 🔑findings: Median f/u: 21.3 mon Median PFS: 15.0 mon(Inavo) vs 7.3 mon (control) (HR 0.43; p<0.0001) ORR: 58.4% (Inavo) vs 25% (control) Consistent benefit across key subgroups @dr-rshatsky.bsky.social 364
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20255/20 #TumorBoardTuesday 👩⚕️Mini Tutorial 2👩⚕️ Pt characteristics in INAVO120: No prior treatment for ABC PIK3CA mut a1c≤6.0, fasting BG<126 ~Half with ≥3 involved organ sites ~Half with liver involvement, ~40% with 🫁 involvement ~1/3 with 1° endocrine resistance, 2/3 with 2° @dr-rshatsky.bsky.social 264
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20254/20 #TumorBoardTuesday 👩⚕️Mini Tutorial 1👩⚕️ Oct 2024, FDA approved inavolisib, palbociclib, and fulvestrant in endocrine resistant HR+/HER2- advanced breast cancer, based on the phase 3, INAVO120 study @dr-rshatsky.bsky.social 363
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20253/20 #TumorBoardTuesday Tissue NGS was not performed. CtDNA 🧬analysis revealing the following: -PIK3CA H1047R How does this impact your answer to the prior poll? 🤔 @dr-rshatsky.bsky.social 243
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20252/20 #TumorBoardTuesday Poll: What would you do next? 1. Sequence biopsied site of metastatic recurrence +/- ctDNA 2. Start ribociclib, switch endocrine therapy to fulvestrant 3. Start inavolisib, palbociclib and fulvestrant 4. Options 1 and 3 concurrently @dr-rshatsky.bsky.social 543
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 15/01/20251/20 #TumorBoardTuesday ⭐Case 1⭐ 46 y/o pre-menopausal F with L cT2N0, G3 IDC, ER >95%, PR >95%, HER2– (2+) s/p lumpectomy (pT2N0; oncotype RS 13), adjuvant RT, and 2 years into adjuvant OFS+AI, with metastatic recurrence (involving 🫁, thoracic LNs, and 🦴). #MedSky #MBC @dr-rshatsky.bsky.social 244
Dr. RShatsky @dr-rshatsky.bsky.social · 14/01/2025This is happening tonight folks! 8pm Eastern 5 pacific! 073
Reposted by Dr. RShatskyXiaojie (Zoe) Zhang @zoezhang.bsky.social · 10/01/2025So excited to begin my #Medsky journey by presenting with my amazing clinic mentor @dr-rshatsky.bsky.social at #TBT on new developments in HR+ MBC! ! It will be on Tuesday the 14th at 5pm pacific, 8pm eastern! #bcsm #OncSky #CanSky #MedSky #breastcancer #MBC 071
Reposted by Dr. RShatskyStill Waters Osteopathic Medical Clinic @getfitnbelean.bsky.social · 10/01/2025MedSky Influenza Questionnaire; 1. Do you feel like you got hit by a truck? If yes, go to 2. 2. Did you actually get hit by a truck? If no, go to 3. 3. You have the flu. Late surge this year, get your flu shot! 0113
Dr. RShatsky @dr-rshatsky.bsky.social · 09/01/2025Hello all, wanted to let you know about a fantastic interactive learning opportunity! This Tuesday the 14th my lovely fellow and I will be presenting Tumor board Tuesday #TBT about new developments in HR+ MBC! It will be 5pm pacific, 8pm eastern! #bcsm #OncSky #CanSky #MedSky #breastcancer #MBC 4429
Dr. RShatsky @dr-rshatsky.bsky.social · 31/12/2024There is a giant Flu A outbreak and EROncDoc is heading off to his night shift. I just begged him to wear his N95 all night so that he doesn’t bring it home. I Can. Not. Handle. Another virus. I think my nose will fall off and my lungs will jump out of my chest if I get another one. #MedSky #Flu 190
Dr. RShatsky @dr-rshatsky.bsky.social · 31/12/2024Ga I still haven’t figured this platform out completely I just deleted my own post by accident. I accidentally deleted a post where I was making fun of my own lack of tech skills. How ironic and poignant. 050
Dr. RShatsky @dr-rshatsky.bsky.social · 31/12/2024If I’ve been quiet on social media for awhile it’s because 1. I have been spending some much needed family time with extended family and 2.I’ve been sick with all the cold viruses one could possibly get. My toddler’s preschool keeps my family in constant virus battle. It’s not…awesome. Sigh. 140